Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Raed Alroughani et al.|JAMA Neurology|2023Cited by 62
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Melinda Magyari, Nupur Greene et al.|Brain Communications|2024Cited by 8
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide studyMalte Roar, Tobias Sejbæk, Amalie Rhode Høgh Nielsen et al.|Multiple Sclerosis and Related Disorders|2023Cited by 3